Saturday - August 9, 2025
AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
July 31, 2025
ST. LOUIS, Missouri, July 31 -- The Siteman Cancer Center issued the following news:

* * *

AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation

By Julia Evangelou Strait, WashU Medicine

Software developed at WashU Medicine on accelerated path to approval

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of develop . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products